SOURCE: BioElectronics Corporation

BioElectronics Corporation

October 20, 2009 11:00 ET

BioElectronics Announces Financial Audit

FREDERICK, MD--(Marketwire - October 20, 2009) - BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has retained independent accounting firm Berenfeld Spritzer Schechter & Sheer for accounting and auditing services.

"With over 200 accounting and auditing professionals, Berenfeld is highly qualified to manage our accounting and auditing needs. BioElectronics is now reaching the point where a full audit will more fully assist our investors, distributors and business partners to understand our strengthening business operations," commented Rick Staelin, chairman of the board of BioElectronics Corp. "The availability of fully audited financial statements will also allow us increased flexibility relative to movement to other stock trading venues and will enhance our ability to partner with other business entities potentially strengthening our branding and distribution efforts."

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx™ Devices, HealFast® Therapy ( and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see

Contact Information

  • For media enquiries, please contact:
    Joe Noel
    (925) 922-2560